Overview
Katherine Crew is an Oncologist in New York, New York. Dr. Crew is rated as an Advanced provider by MediFind in the treatment of Breast Cancer in Men. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy.
Her clinical research consists of co-authoring 151 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Breast Cancer in Men.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
622 W 168th St, New York, NY 10032
161 Fort Washington Ave, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Yale University
Eric Winer is an Oncologist and a Hematologist Oncology provider in New Haven, Connecticut. Dr. Winer is rated as an Elite provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, HER-2 Positive Breast Cancer, and Breast Cancer in Men.
Memorial Solid Tumor Group
Mark Robson is an Oncologist in New York, New York. Dr. Robson is rated as an Elite provider by MediFind in the treatment of Breast Cancer in Men. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Breast Cancer in Men, Ovarian Cancer, and Salpingo-Oophorectomy.
Memorial Solid Tumor Group
Ayca Gucalp is an Oncologist in New York, New York. Dr. Gucalp is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer in Men. Her top areas of expertise are Breast Cancer, Breast Cancer in Men, Triple-Negative Breast Cancer, and Paget Disease of the Breast.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Crew isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Crew isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Crew isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Crew isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- BRCA Positive Breast CancerDr. Crew isAdvanced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Crew isAdvanced. Learn about Breast Cancer in Men.
- HER2 Negative Breast CancerDr. Crew isAdvanced. Learn about HER2 Negative Breast Cancer.
- MenopauseDr. Crew isAdvanced. Learn about Menopause.
- Experienced
- Anaplastic Large Cell LymphomaDr. Crew isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- DICER1 SyndromeDr. Crew isExperienced. Learn about DICER1 Syndrome.
- Familial Pancreatic CancerDr. Crew isExperienced. Learn about Familial Pancreatic Cancer.
- HER-2 Positive Breast CancerDr. Crew isExperienced. Learn about HER-2 Positive Breast Cancer.
- Ovarian CancerDr. Crew isExperienced. Learn about Ovarian Cancer.
- Pancreatic CancerDr. Crew isExperienced. Learn about Pancreatic Cancer.